logo.png
Orphazyme announces topline data from pivotal trial of arimoclomol in Amyotrophic Lateral Sclerosis (ALS)
07 mai 2021 01h00 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcementNo. 14/2021Inside informationCompany Registration No. 32266355 Pivotal trial did not meet primary and secondary endpoints evaluating impact on function and...
logo.png
Orphazyme to present at upcoming investor conferences
27 avr. 2021 16h05 HE | ORPHAZYME A/S
Orphazyme A/SInvestor news        No. 05/2021Company Registration No. 32266355 Copenhagen, Denmark and Chicago, IL, USA, April 27, 2021 – Orphazyme A/S [ORPHA.CO (DK); ORPH (US)], a late-stage...
logo.png
New long-term share-based incentive program
22 avr. 2021 00h34 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcement        No. 13/2021Company Registration No. 32266355 Copenhagen, Denmark, April 22, 2021 – Orphazyme A/S [ORPHA.CO (DK); ORPH (US)], a late-stage biopharmaceutical...
logo.png
Orphazyme announces topline results from pivotal trial of arimoclomol for Inclusion Body Myositis (IBM)
29 mars 2021 01h00 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcement                                                                                       No. 12/2021Inside informationCompany Registration No. 32266355 Copenhagen –...
logo.png
Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities
25 mars 2021 15h48 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcement                                                                                       No....
logo.png
Articles of Association for Orphazyme A/S
25 mars 2021 15h37 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcement                                                                                       No. 10/2021                                                                     ...
logo.png
Capital increase of 3,854 shares in Orphazyme A/S as a result of the exercise of Restricted Share Units
25 mars 2021 15h20 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcement                                                                                       No....
logo.png
Resolutions passed at the Annual General Meeting
25 mars 2021 13h53 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcement                                                                                       No....
logo.png
Correction: Notice to convene Annual General Meeting
03 mars 2021 13h06 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcement                                                                                       No. 07/2021                                                                     ...
logo.png
Notice to convene Annual General Meeting
03 mars 2021 10h00 HE | ORPHAZYME A/S
Orphazyme A/SCompany announcement                                                                                       No. 07/2021                                                                     ...